The shareholders of
ENTITLEMENT TO PARTICIPATE AND NOTICE
A shareholder who would like to participate in the meeting must (i) be entered in the register of shareholders maintained by
In order to be entitled to participate in the meeting, shareholders who have registered their shares in the name of a nominee must, in addition to announcing their intention to participate in the meeting, request that their shares be registered in their own name so the shareholder is entered into the register of shareholders by
ADVANCE VOTING
The shareholders may exercise their voting rights at the Meeting only by voting in advance, so called postal voting in accordance with Section 22 of the Act (2020:198) on temporary exceptions to facilitate the execution of general meetings in companies and other associations. A special form shall be used for advance voting. The form is available at www.activebiotech.com. The advance voting form is considered as the notification of participation at the Meeting. The completed voting form must be received by company no later than Friday,
PROPOSED AGENDA
- Election of Chairman of the Meeting
- Preparation and approval of the voting list
- Election of one or two persons to verify the minutes
- Approval of the agenda for the Meeting
- Determination of whether the Meeting has been duly convened
- The Board of Director’s proposal to issue new shares
PROPOSED RESOLUTIONS
Chairman of the Meeting (item 1)
The board proposes that Erik Sjöman is elected Chairman of the Meeting or, if he is prevented from doing so, the person that the board appoints instead.
Voting list (item 2)
The voting list proposed for approval under item 2 on the agenda is the voting list prepared by the company, based on the shareholders’ register and advance votes received, and verified by the persons elected to verify the minutes.
Persons to verify the minutes (item 3)
New share issue (item 6)
The Board of Directors proposes that the Meeting resolves to increase the company’s share capital through issue of new shares.
The shareholders of the company shall be entitled to subscribe for the new shares with pre-emptive rights. Subscription can also be made without any pre-emptive rights, as set forth in the complete issue resolution.
The record date for the right to participate in the rights issue shall be
The board of directors shall, not later than
For further details and information of background to and reasons for the rights issue, refer to Active Biotech’s press release on
___________________
FURTHER INFORMATION
Number of shares and votes
There are a total of 145,236,480 shares and votes in
Questions and shareholders’ right to request information
At an extraordinary general meeting, if any shareholder should so request and the board of the company assesses that this can be done without significant damage to the company, the board and the CEO of the company shall provide information about conditions that could affect the assessment of items on the agenda and the company’ s relationship to other group companies. A request for such information shall be made by e-mail to susanne.jonsson@activebiotech.com or by mail to
Available documentation and proxy forms
The complete documentation for the Meeting will be presented by being made available at the company’s offices and the company’s website, www.activebiotech.com, no later than three weeks before the Meeting and will be sent free of charge to all shareholders who so request and provide their postal address. The shareholders’ register for the Meeting is also made available at the company. Proxy form for shareholders who wish to vote in advance by proxy is available on the company’s website and will be sent free of charge to all shareholders who so request and provide their postal address.
Processing of personal data
For information about the processing of your personal data, please refer to https://www.euroclear.com/dam/ESw/Legal/Privacy-notice-bolagsstammor-engelska.pdf. Active Biotech’s AB (publ) corporate registration number is 556223-9227 and its registered office is in
The Board of Directors of
Attachment
- NOTICE OF EXTRAORDINARY GENERAL MEETING IN ACTIVE BIOTECH
© OMX, source